Ibaseta A, Rahman R, Andrade NS, et al. - Researchers performed a retrospective cohort study examining the risks and benefits of crossing the cervicothoracic junction (CTJ) in cervical arthrodesis. Among 168 patients who underwent cervical spine fusion surgery ending at C7 or T1 with ≥ 1-year follow-up, a C7 end-of-fusion cohort comprised 59 patients and a T1 end-of-fusion cohort comprised 109 patients. Outcomes revealed no increase in operative risk in correlation with crossing the CTJ in cervical arthrodesis as measured by blood loss, operative time, and length of hospital stay. However, it results in lower revision rates, likely due to the avoidance of adjacent segment disease (ASD), and comparable patient-reported outcomes (PROs). Thus, ASD could be avoided by crossing the CTJ with no negative impact on operative risk or long-term PROs.